Drug Information

Drug General Information
Drug ID
D0GR6H
Former ID
DNC007896
Drug Name
2-benzoylaminoquinazoline-4-carboxyanilide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529186]
Formula
C22H16N4O2
Canonical SMILES
C1=CC=C(C=C1)C(=O)NC2=NC3=CC=CC=C3C(=N2)C(=O)NC4=CC=CC=<br />C4
InChI
1S/C22H16N4O2/c27-20(15-9-3-1-4-10-15)26-22-24-18-14-8-7-13-17(18)19(25-22)21(28)23-16-11-5-2-6-12-16/h1-14H,(H,23,28)(H,24,25,26,27)
InChIKey
RQQPFMNLXURQFV-UHFFFAOYSA-N
PubChem Compound ID
24749708
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [529186]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 529186J Med Chem. 2007 Dec 27;50(26):6596-606. Epub 2007 Nov 30.Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study.
Ref 529186J Med Chem. 2007 Dec 27;50(26):6596-606. Epub 2007 Nov 30.Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.